Editorial: Infliximab Trough Cut-Off for Perianal Crohn's Disease - Another Piece of the Therapeutic Drug Monitoring-Guided Infliximab Dosing Puzzle

Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.14020
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Higher Infliximab Trough Levels Are Associated With Perianal Fistula Healing in Patients With Crohn's Disease

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease

New England Journal of Medicine
Medicine
2010English

Trough Level of Infliximab Is Useful for Assessing Mucosal Healing in Crohn's Disease: A Prospective Cohort Study

Intestinal Research
Gastroenterology
2018English

Editorial: First Among Equals-Not for Either Infliximab or Adalimumab in Crohn's Disease-Yet

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Efficacy of Infliximab Biosimilars in Patients With Crohn's Disease

The Lancet
Medicine
2017English

The Combined Use of Disease Activity and Infliximab Serum Trough Concentrations for Early Prediction of (Non-)Response to Infliximab in Rheumatoid Arthritis

British Journal of Clinical Pharmacology
Pharmacology
2013English

Editorial: Infliximab De-Escalation in Inflammatory Bowel Disease Using a Therapeutic Drug Monitoring Strategy - Early Promise but More Data Needed. Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

Infliximab and Adalimumab Drug Levels in Crohn's Disease: Contrasting Associations With Disease Activity and Influencing Factors

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Another Piece in the BRCA1 Puzzle

Nature Structural and Molecular Biology
Structural BiologyMolecular Biology
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy